Kim Boltonmonday.com Ltd.MNDYDON'T BUYFeb 05, 2026

Falls into the category of software applications, which she's avoiding. The scare is that AI tools will replace its products.

Whether to sell is tricky. Rotating into a new idea usually performs better than a stale one. Probably best to sell at least half.

It's a small company, so it's numbers pale compared to the billions of the likes of MSFT and such. Took a 40% haircut because everyone's worried about it. But it's cheap now, compelling valuation of 14% cashflow for 2026 and 4x revenue. They definitely have leadership in the no-code arena. He recently added more.

Caught up in the narrative of AI eating the lunch of a lot of software companies. He sold. Software is not the key to the AI revolution, but hardware is. Might be a good candidate for a tax loss.

In last quarterly report, company stated that small and medium companies weren't buying as much as expected. AI can do a lot of what it can. Customers now have "buy or build" options out there. Trades at 52x PE, with negative momentum. Tax-loss selling candidate.

Great runway ahead. Last reporting was fantastic. Has made a lot of hay with data centres and hyperscalers.

He targets $321. They reported on Nov.10 and raised guidance, but missed the top, met at the bottom. They brought in a new COO, who came from Alexa. Their total addressable market has expanded.

12-month target of $268. He's trimmed a bit. Has really jumped on the AI trend.

Doesn't know about takeover bid. Is a mini "salesforce.com". Would not bet against them. Should probably buy. 

Loves this one. 12-month price of $266, good long runway.

On track to have their first profitable year in 2023. Free cash flow is on track to be up 700% though from a very low number. Passes the rule of 40 test, where revenue growth + free cash flow margin passes 40.

Work collaboration. Israeli company. Claim to fame is that it has almost-no-code technology, so you don't have to be a tech whiz. Software is intuitive. Still unprofitable, but anticipates profitability by Q4, earlier than expected. Price target of $226.25. No dividend.